Q4 2018 Holdings
Filed 2019-02-13 | 20 holdings | $34.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arvinas Inc(ARVN) | COM | 04335A105 | $29.3M | 2,283,048 | 84.6% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $5.0M | 167,700 | 14.5% |
| Deciphera Pharmaceuticals Inc(DCPHEUR) | COM | 24344T101 | $86.1K | 4,104,140 | 0.2% |
| Principia Biopharma Inc(PRNB) | COM | 74257L108 | $71.9K | 2,625,713 | 0.2% |
| Aptynix Inc | COM | 03836N103 | $54.4K | 3,290,079 | 0.2% |
| Neuronetics Inc(STIM) | COM | 64131A105 | $29.9K | 1,543,115 | 0.1% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $17.9K | 425,429 | 0.1% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $12.7K | 444,708 | 0.0% |
| Obseva SA | COM | H5861P103 | $11.4K | 900,501 | 0.0% |
| Unum Therapeutics Inc | COM | 903214104 | $7.9K | 1,795,545 | 0.0% |
| Iterum Therapeutics PLC | SHS | G6333L101 | $7.3K | 1,456,303 | 0.0% |
| Sierra Oncology Inc | COM | 82640U107 | $6.6K | 5,020,446 | 0.0% |
| Affimed N V | COM | N01045108 | $5.6K | 1,800,000 | 0.0% |
| Avrobio Inc | COM | 05455M100 | $3.6K | 215,550 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $3.5K | 1,350,000 | 0.0% |
| Proteon Therapeutics Inc | COM | 74371L109 | $3.5K | 1,523,200 | 0.0% |
| Aravive Inc | COM | 92529L102 | $3.4K | 970,659 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $2.9K | 423,300 | 0.0% |
| Edge Therapeutics Inc | COM | 279870109 | $753 | 2,344,868 | 0.0% |
| Aveo Pharmaceuticals Inc(AVEOEUR) | COM | 053588109 | $643 | 402,118 | 0.0% |